Bibliography

Export 65 results:
Filters: Author is Penn,I. and Keyword is *Kidney Transplantation  [Clear All Filters]
1976
Mullen DL, Silverberg SG, Penn I, Hammond WS. Squamous cell carcinoma of the skin and lip in renal homograft recipients. Cancer. 1976;37(2):729-34.
1975
Wilson RE, Penn I. Fate of tumors transplanted with a renal allograft. Transplant Proc. 1975;7(2):327-31.
Porreco R, Penn I, Droegemueller W, Greer B, Makowski E. Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol. 1975;45(4):359-64.
Penn I. Immunosuppression and cancer. Importance in head and neck surgery. Arch Otolaryngol. 1975;101(11):667-70.
Penn I. The incidence of malignancies in transplant recipients. Transplant Proc. 1975;7(2):323-6.
1974
Koranda FC, Dehmel EM, Kahn G, Penn I. Cutaneous complications in immunosuppressed renal homograft recipients. Jama. 1974;229(4):419-24.
Starzl TE, Porter KA, Halgrimson CG, Husberg BS, Penn I, Putnam CW. A decade followup in early cases of renal homotransplantation. Ann Surg. 1974;180(4):606-16.
1973
Starzl TE, Groth CG, Putnam CW, Corman J, Halgrimson CG, Penn I, et al. Cyclophosphamide for clinical renal and hepatic transplantation. Transplant Proc. 1973;5(1):511-6.
Halgrimson CG, Penn I, Booth A, Groth C, Putnam CW, Corman J, et al. Eight- to ten-year follow-up in early cases of renal homotransplantation. Transplant Proc. 1973;5(1):787-91.
Gustafsson A, Groth CG, Halgrimson CG, Penn I, Starzl TE. The fate of failed renal homografts retained after retransplantation. Surg Gynecol Obstet. 1973;137(1):40-2.
Penn I. Transplantation of kidneys containing primary malignant tumors. Transplantation. 1973;16(6):674-5.
Corman JL, Kashiwagi N, Porter KA, Andres G, Iwatsuki S, Putnam CW, et al. Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment. Transplantation. 1973;16(1):60-3.
1972
Penn I, Durst AL, Machado M, Halgrimson CG, S., Bynon J. J, Putman CW, et al. Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg. 1972;105(2):167-72.
Penn I, Starzl TE. Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation. 1972;14(4):407-17.
Starzl TE, Putnam CW, Halgrimson CG, Groth CG, S., Bynon J. J, Penn I. Renal transplantation under cyclophosphamide. Transplant Proc. 1972;4(4):461-4.
Penn I, Starzl TE. A summary of the status of de novo cancer in transplant recipients. Transplant Proc. 1972;4(4):719-32.
Penn I, Mackie G, Halgrimson CG, Starzl TE. Testicular complications following renal transplantation. Ann Surg. 1972;176(6):697-9.
1971
Aldrete JA, Swanson JT, Penn I, Starzl TE. Anesthesia experience with living renal transplant donors. Anesth Analg. 1971;50(2):169-74.
Starzl TE, Halgrimson CG, Penn I, Martineau G, Schroter G, Amemiya H, et al. Cyclophosphamide and human organ transplantation. Lancet. 1971;2(7715):70-4.
Penn I, Halgrimson CG, Starzl TE. De novo malignant tumors in organ transplant recipients. Transplant Proc. 1971;3(1):773-8.
Schneck SA, Penn I. De-novo brain tumours in renal-transplant recipients. Lancet. 1971;1(7707):983-6.
Starzl TE, Penn I, Putnam CW, Groth CG, Halgrimson CG. Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev. 1971;7:112-45.
Torisu M, Yokoyama T, Amemiya H, Kohler PF, Schroter G, Martineau G, et al. Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen. Ann Surg. 1971;174(4):620-39.
Halgrimson CG, Rapaport FT, Terasaki PI, Porter KA, Andres G, Penn I, et al. Net histocompatibility ratios (NHR) for clinical transplantation. Transplant Proc. 1971;3(1):140-4.
Penn I, Makowski E, Droegemueller W, Halgrimson CG, Starzl TE. Parenthood in renal homograft recipients. Jama. 1971;216(11):1755-61.

Pages